Wharton's Jelly Mesenchymal Stem Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Wharton's Jelly Mesenchymal Stem Cells, covering 2025-05-25 to 2025-05-25. Get the full timeline:
Most recent: Clinical Trial Update: Guttmann NeuroRecovery - Viability, Safety, and Efficacy of Intrathecal Wharton's Jelly Mesenchymal Stem Cells and Transcutaneous Spinal Cord Stimulation in Chronic Spinal Cord Injury Rehabilitation [Phase 1, Phase 2]